Compare IRTC & WHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | WHD |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.9B |
| IPO Year | 2016 | 2018 |
| Metric | IRTC | WHD |
|---|---|---|
| Price | $118.76 | $57.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $197.92 | $56.33 |
| AVG Volume (30 Days) | 452.1K | ★ 648.0K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | ★ 61.71 | 18.99 |
| EPS | N/A | ★ 0.19 |
| Revenue | $747,138,000.00 | ★ $1,079,051,000.00 |
| Revenue This Year | $19.60 | $43.92 |
| Revenue Next Year | $15.94 | $6.83 |
| P/E Ratio | ★ N/A | $297.84 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $112.31 | $33.30 |
| 52 Week High | $210.01 | $59.25 |
| Indicator | IRTC | WHD |
|---|---|---|
| Relative Strength Index (RSI) | 46.34 | 62.11 |
| Support Level | $112.65 | $55.80 |
| Resistance Level | $127.50 | $58.53 |
| Average True Range (ATR) | 6.63 | 1.56 |
| MACD | -0.33 | -0.01 |
| Stochastic Oscillator | 28.04 | 91.55 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.